Find out more about Peter Savas' experience
Peter Savas' highlights
Displaying the 3 most recent scholarly works by Peter Savas.
Pervasive chromosomal instability and karyotype order in tumour evolution
Thomas BK Watkins, Emilia L Lim, Marina Petkovic, Sergi Elizalde, Nicolai J Birkbak, Gareth A Wilson, David A Moore, Eva Gronroos, Andrew Rowan, Sally M Dewhurst, Jonas Demeulemeester, Stefan C Dentro, Stuart Horswell, Lewis Au, Kerstin Haase, Mickael Escudero, Rachel Rosenthal, Maise Al Bakir, Hang Xu, Kevin Litchfield, et al.
Journal article | 2020 | Nature
Chromosomal instability in cancer consists of dynamic changes to the number and structure of chromosomes1,2. The resulting diversi..
Clinical implications of prospective genomic profiling of metastatic breast cancer patients
Courtney T van Geelen, Peter Savas, Zhi Ling Teo, Stephen J Luen, Chen-Fang Weng, Yi-An Ko, Keilly S Kuykhoven, Franco Caramia, Roberto Salgado, Prudence A Francis, Sarah-Jane Dawson, Stephen B Fox, Andrew Fellowes, Sherene Loi
Journal article | 2020 | Breast Cancer Research
BACKGROUND: Metastatic breast cancer remains incurable. Next-generation sequencing (NGS) offers the ability to identify actionable..
Phase 1b study evaluating a triplet combination of ipatasertib (IPAT), atezolizumab (Atezo), and paclitaxel (PAC) or nab-PAC as first-line (1L) therapy for locally advanced/metastatic triple-negative breast cancer (aTNBC)
P Schmid, S Kuemmel, D Loirat, P Savas, E Espinosa, V Boni, A Italiano, S White, S Singel, N Withana, A Mani, S Li, A Harris, M Wongchenko, M Sablin
Conference Proceedings | 2020 | GEBURTSHILFE UND FRAUENHEILKUNDE
The Sir Peter MacCallum Department of Oncology